NT-proBNP versus routine clinical risk factors as a predictor of cardiovascular events or death in people with dysglycemia - A brief report from the ORIGIN trial.

Magnus O Wijkman,Hertzel C Gerstein,Matthew Mcqueen,Brian L Claggett,Shun Fu Lee,Sibylle Hess,Guillaume Paré,Marc A Pfeffer

doi:10.1016/j.jdiacomp.2021.107928

NT-proBNP versus routine clinical risk factors as a predictor of cardiovascular events or death in people with dysglycemia - A brief report from the ORIGIN trial.

Magnus O Wijkman, Hertzel C Gerstein + Show 6 more

Open Access

https://doi.org/10.1016/j.jdiacomp.2021.107928

Copy DOI

Journal: Journal of Diabetes and its Complications	Publication Date: Apr 16, 2021
Citations: 2	License type: cc-by

Affiliation: Brigham and Women's Hospital, Harvard University, Linköping University, Hamilton Health Sciences, McMaster University, Population Health Research Institute, Sanofi (Germany)

#ORIGIN Trial #Prediction Of Cardiovascular Events + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

In patients with diabetes and cardiovascular or renal comorbidities, circulating levels of the N-terminal fragment of prohormone B-type natriuretic peptide (NT-proBNP) have similar discriminatory ability as multivariate models for prediction of cardiovascular events or death. We validated this finding in patients with dysglycemia not selected for co-existing cardiorenal diseases.

Full Text